- Home
- PSMT vs KYMR Comparison
PSMT vs KYMR Comparison
Compare PSMT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSMT | KYMR |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.7B |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PSMT | KYMR |
|---|---|---|
| Price | $126.09 | $92.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 22 |
| Target Price | N/A | ★ $96.32 |
| AVG Volume (30 Days) | 153.3K | ★ 1.1M |
| Earning Date | 01-07-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | ★ 5.57 | N/A |
| EPS | ★ 4.82 | N/A |
| Revenue | ★ $5,270,094,000.00 | $43,735,000.00 |
| Revenue This Year | $10.66 | $20.81 |
| Revenue Next Year | $9.64 | N/A |
| P/E Ratio | $26.09 | ★ N/A |
| Revenue Growth | ★ 7.25 | N/A |
| 52 Week Low | $81.25 | $19.45 |
| 52 Week High | $129.16 | $103.00 |
Technical Indicators
Market Signals| Indicator | PSMT | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 60.01 | 74.39 |
| Support Level | $123.95 | $85.00 |
| Resistance Level | $129.16 | $103.00 |
| Average True Range (ATR) | 3.23 | 4.25 |
| MACD | 0.50 | 2.46 |
| Stochastic Oscillator | 75.87 | 66.37 |
Price Performance
Historical ComparisonAbout PSMT PriceSmart Inc.
Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.